Screener
Aurinia Pharmaceuticals AUPH Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's gross margin?
- Aurinia Pharmaceuticals (AUPH) reported gross margin of 90.4% in Q2 2026.
- How has Aurinia Pharmaceuticals's gross margin changed year-over-year?
- Aurinia Pharmaceuticals's gross margin increased by 0.9% year-over-year, from 89.5% to 90.4%.
- What is the long-term trend for Aurinia Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's gross margin has grown at a -2.4% compound annual growth rate (CAGR), from 100% to 88.5%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Aurinia Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude